Avaleht › Põievähk › Illinois › Chicago
Põievähk kliinilised uuringud linnas Chicago, IL
21 uuringut haiguse Põievähk jaoks otsivad osalejaid linnas Chicago ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
VärbamineFaas 1
- University of Chicago Hospital, Chicago
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
VärbamineFaas 1/2
- University of Chicago Medical Center ( Site 5037), Chicago
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
VärbamineFaas 3
- Northwestern University, Chicago
- University of Illinois, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- ja veel 1
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
VärbamineFaas 2
- Rush MD Anderson Cancer Center, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
VärbamineFaas 2
- University of Illinois Cancer Center, Chicago
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
VärbamineFaas 2
- Northwestern University, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
VärbamineFaas 2
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
VärbamineFaas 1
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
VärbamineFaas 3
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
VärbamineFaas 1
- The University of Chicago Medical Center (UCMC), Chicago
Measuring Surgical Recovery After Radical Cystectomy
VärbamineVaatlusuuring
- University of Chicago, Chicago
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
VärbamineFaas 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
VärbamineFaas 2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
VärbamineFaas 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
VärbamineFaas 2
- Northwestern University, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
VärbamineFaas 1
- The University of Chicago Comprehensive Cancer Center, Chicago
Blue Light Cystoscopy With Cysview® Registry
VärbamineVaatlusuuring
- Northwestern University, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Chicago
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
VärbamineVaatlusuuring
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
Värbamine
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Põievähk uuringud teistes linnades
- New York City, NY35 uuringut
- Nashville, TN31 uuringut
- Houston, TX31 uuringut
- Dallas, TX27 uuringut
- Boston, MA26 uuringut
- Washington, DC26 uuringut
- Los Angeles, CA24 uuringut
- Baltimore, MD24 uuringut
- St. Louis, MO22 uuringut
- Philadelphia, PA21 uuringut
- Seattle, WA21 uuringut
- Edison, NJ21 uuringut
Muud uuringud linnas Chicago
- Mitteväikerakuline kopsuvähk61 uuringut
- Rinnavähk58 uuringut
- Vähk (kõik liigid)51 uuringut
- Metastaatiline vähk45 uuringut
- Eesnäärmevähk45 uuringut
- Rasvumine41 uuringut
- Kopsuvähk41 uuringut
- Munasarjavähk36 uuringut
- Insult34 uuringut
- Käär- ja pärasoolevähk33 uuringut
- Südamepuudulikkus31 uuringut
- Ülekaalulisus28 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.